The First Scalable Organoid Platform

Reproducible organoid screening models at scale

NaviPlate is a novel 384-well plate for highly reproducible, mature organoid models.

The first of its kind, NaviPlate is automated, enabling high precision, scalable screening of drug candidates in organoid models.

Designed with user flexibility in mind, NaviPlate ensures early detection of lead candidates for optimised clinical development.

  • Low Cell Count Required - Suitable for patient-derived materials

  • User Friendly - No complex cell culture protocols

  • Flexible Models - Adaptable to desired model and assays

  • Easily Integrated - Compatible with standard equipment automations

Our First Indications

Renal

Cardiac

Oncology

Team

Dr Elad Katz

Dr Lindsay Davidson

Get In Touch

To find out more about our models and discuss your screen of interest, get in touch today.